Business Description
Eurobio Scientific
ISIN : FR0013240934
Share Class Description:
XPAR:ALERS: Bearer and/or Registered shares issued from reverse splitTotal Employee Number:
343Compare
Compare
Traded in other countries / regions
ALERS.FranceE8TN.Germany IPO Date
2005-11-17Description
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 0.6 | |||||
Interest Coverage | 5.55 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.74 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7 | |||||
3-Year EBITDA Growth Rate | -9.7 | |||||
3-Year EPS without NRI Growth Rate | -40.2 | |||||
3-Year FCF Growth Rate | -44.2 | |||||
3-Year Book Growth Rate | 2.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.19 | |||||
9-Day RSI | 44.1 | |||||
14-Day RSI | 44.07 | |||||
3-1 Month Momentum % | -6.11 | |||||
6-1 Month Momentum % | -8.7 | |||||
12-1 Month Momentum % | -15.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.98 | |||||
Quick Ratio | 1.36 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 113 | |||||
Days Sales Outstanding | 72.71 | |||||
Days Payable | 64.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.5 | |||||
Shareholder Yield % | 16.63 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.58 | |||||
Operating Margin % | 6.37 | |||||
Net Margin % | 2.89 | |||||
EBITDA Margin % | 15.83 | |||||
FCF Margin % | 3.73 | |||||
OCF Margin % | 11.18 | |||||
ROE % | 2.68 | |||||
ROA % | 1.89 | |||||
ROIC % | 3.18 | |||||
3-Year ROIIC % | 108.31 | |||||
ROC (Joel Greenblatt) % | 24.5 | |||||
ROCE % | 4.55 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 45.11 | |||||
Forward PE Ratio | 19.03 | |||||
PE Ratio without NRI | 44.17 | |||||
Shiller PE Ratio | 15.37 | |||||
Price-to-Owner-Earnings | 17.44 | |||||
PS Ratio | 1.29 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 6.43 | |||||
Price-to-Free-Cash-Flow | 34.48 | |||||
Price-to-Operating-Cash-Flow | 11.61 | |||||
EV-to-EBIT | 20.91 | |||||
EV-to-EBITDA | 7.62 | |||||
EV-to-Forward-EBITDA | 5.28 | |||||
EV-to-Revenue | 1.21 | |||||
EV-to-Forward-Revenue | 1.52 | |||||
EV-to-FCF | 32.91 | |||||
Price-to-GF-Value | 0.82 | |||||
Price-to-Projected-FCF | 0.43 | |||||
Price-to-Median-PS-Value | 1.13 | |||||
Price-to-Graham-Number | 3.51 | |||||
| Price-to-Net-Current-Asset-Value | 11.13 | |||||
Earnings Yield (Greenblatt) % | 4.77 | |||||
FCF Yield % | 3.01 | |||||
Forward Rate of Return (Yacktman) % | -8.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurobio Scientific Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 168.595 | ||
| EPS (TTM) (€) | 0.47 | ||
| Beta | 0.4505 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 1.19 | ||
| Volatility % | 19.57 | ||
| 14-Day RSI | 44.07 | ||
| 14-Day ATR (€) | 0.74485 | ||
| 20-Day SMA (€) | 21.085 | ||
| 12-1 Month Momentum % | -15.35 | ||
| 52-Week Range (€) | 19.3 - 25.7 | ||
| Shares Outstanding (Mil) | 10.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurobio Scientific Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurobio Scientific Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2017-09-01 | 6.00 (+0.00%) | ||
| 1000:1 Stock Split | 2001-05-28 | -- |
Show
Entries
Eurobio Scientific Frequently Asked Questions
What is Eurobio Scientific(XPAR:ALERS)'s stock price today?
The current price of XPAR:ALERS is €20.70. The 52 week high of XPAR:ALERS is €25.70 and 52 week low is €19.30.
When is next earnings date of Eurobio Scientific(XPAR:ALERS)?
The next earnings date of Eurobio Scientific(XPAR:ALERS) is .
Does Eurobio Scientific(XPAR:ALERS) pay dividends? If so, how much?
Eurobio Scientific(XPAR:ALERS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Eurobio Scientific
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers